本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

89Bio, Inc.

5.77
-1.0900-15.89%
盘后:5.73-0.0435-0.75%19:55 EDT
成交量:349.81万
成交额:2,070.61万
市值:8.42亿
市盈率:-1.65
高:6.80
开:6.58
低:5.55
收:6.86
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
数据加载中...
2021/03/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/23

重要事件披露

8-K - Current report
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/10/04

重要事件披露

8-K - Current report
2020/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/13

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/05

SEC问询函

CORRESP [Cover] - Correspondence

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”